Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MELI vs GSK✓SelectedUSD · GSKMELI vs GSK performance historyLatest closeAs of-0.04%11/20
Stock and ETF performance explorer

MELI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4,806.5%
GSK return
+137.8%
Excess return
+4,668.7%
Maximum drawdown
-89.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%-0.1%+0.1%0.0%
7D-9.2%-5.3%-3.8%-6.1%
30D-26.9%-3.7%-23.3%-25.4%
3M-29.5%-7.3%-22.2%-26.5%
6M-17.9%-4.2%-13.7%-16.9%
YTD-32.7%+0.9%-33.6%-34.9%
1Y-28.7%+7.3%-36.0%-33.7%
3Y-8.6%+52.7%-61.3%-37.4%
5Y-3.3%+40.1%-43.4%-31.5%
10Y+762.4%+98.7%+663.7%+338.5%
All+4,806.5%+137.8%+4,668.7%+1,996.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling